Point72 Middle East FZE’s NovoCure NVCR Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-47,682	Closed	-$770K	–	1266
2023 Q3	$770K	Buy	47,682 +43,702	+1,098%	+$706K	0.03%	336
2023 Q2	$165K	Sell	3,980 -11,798	-75%	-$490K	﹤0.01%	632
2023 Q1	$949K	Buy	+15,778	New	+$949K	0.03%	249